Traws Pharma, Inc. (TRAW) stock
TRAWNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.23−0.01 (-5.15%)
Close on Nov 19, 2026Market cap $3.53MP/E –Yield –
Traws Pharma free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Traws Pharma's free cash flow for the twelve months ending Dec 31, 2025 was -$20.77M. For fiscal 2025 it was -$20.77M. The highest annual figure on record is $1.35M in fiscal 2012.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$20.77M | – |
| FY2024 | Dec 31, 2024 | -$33.44M | – |
| FY2023 | Dec 31, 2023 | -$17.95M | – |
| FY2020 | Dec 31, 2020 | -$23.09M | – |
| FY2019 | Dec 31, 2019 | -$20.89M | – |
| FY2014 | Dec 31, 2014 | -$57.88M | – |
| FY2013 | Dec 31, 2013 | -$61.99M | -4678.5% |
| FY2012 | Dec 31, 2012 | $1.35M | – |
| FY2011 | Dec 31, 2011 | -$14.43M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | -$2.76M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.04M | – |
| Q3 FY2024 | Sep 30, 2024 | -$11.48M | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.43M | – |
| Q4 FY2020 | Dec 31, 2020 | -$5.47M | – |
| Q3 FY2020 | Sep 30, 2020 | -$5.76M | – |
| Q4 FY2019 | Dec 31, 2019 | -$5.36M | – |
See a number that looks wrong?